Thanks for the comments everyone.
The thing that continues to confound me is the way my PSA appeared to double in 12 months, then went back to down to the "baseline" level 3 weeks later. And even more confusing is these 2 most recent *lower* readings (of about 5 - both in Sept) were taken after several long bike trips (70km+ each day, for 2-3 days each, *before* the lower blood tests - 7th to 9th Sept and 14th/15th Sept), whereas the one I had at the end of August (about 10), was after not riding for 3 weeks or so.
See this 12 month history of my PSA levels:
25th Sept 2023 - 4.99
4th Jan 2024 - 7.1
7th Feb 2024 - 6.55
11th June 2024 - 5.4
30th August 2024 - 10.7
20th September 2024 - 4.90
26th September 2024 - 5.0
Here's these points on a graph, which better illustrates what I'm saying. If I'd not had the PSA test on 30th August then there'd be no upwards trend at all. In fact, the trend would be downwards on this graph.
All I can personally correlate is time of day, which may be incidental but gives me pause to question the usefulness of PSA tests in monitoring disease progression in Active Surveillance. These readings can be influenced by many factors, as mentioned many times on this forum, but time of day is something I hadn't considered until this (and then I found some research indicating there might be a link too).
This therefore leaves me thinking not to be taking PSA readings as a direct measure of disease progression. And, to TechGuy's point, given they've already found some areas scored as 4 (i.e Gleason 3+4) in the biopsy, I'm simply going to go ahead with RARP as that is the most known course of action.
As a side note - I'm lucky to have found a good surgeon at Guy's and have been determined a suitable candidate for surgery with the best possible outcomes (single port / nerve sparing etc - more on that as I learn more, I'm sure). As many suggest on this forum, the best chances of a positive outcome from surgery come from earlier intervention. Quite the dilemma as to when to act though - and one that many here are wrestling with.
Anyway - I'm drawing attention to my own anecdotal observations that PSA trends in Active Surveillance should be taken in a broader context, as a proxy measure. Not, as I was initially led to believe, a clear signal of disease progression (or not).
PS - Good luck with the treatment @AndyWarks and keep us updated on your appointment @JP77
Edited by member 13 Oct 2024 at 20:05
| Reason: Punctuation